Tag Archives: DCGI
The issue of Clinical Trials in India has once again come to the fore with the government’s efforts to woo the mighty pharma industry. The Drug Controller General of India, Mr G N Singh, has been quoted as saying that India will soon roll out a new policy to facilitate clinical trials. It is hence important to understand what are we talking about and why we need to get it right.
PGI Chandigarh to organise conference on organ transplant | PGI director Dr Yogesh Chawla’s tenure comes to an end
As the tenure of PGI director Dr Yogesh Chawla ends on Thursday, dean of the institute, Dr Subhash Verma, has been asked by the union health ministry to take over as PGI director until the new director is appointed.
AIIMS to host World Trauma Congress from Aug 17-20 | Search committee set up for selection of new PGI chief | Govt amends clinical trial procedures
The All India Institute of Medical Sciences (AIIMS), New Delhi will host the World Trauma Congress 2016 from August 17 to 20. According to a recent WHO report, by 2020, trauma will be the third largest killer in the developing world.
New Delhi: The Drugs Controller General of India (DCGI) on Thursday issued an alert, asking states to ensure Swiss drugmaker Roche’s cancer treatment drug Avastin is not administered to treat eyes.
Kolkata: India became the world’s third country with the prowess to manufacture raw materials for nanomedicines, addressed a growing public health concern by approving a new drug for hepatitis C and made strides in 3D printing in healthcare as 2015 ended on a cliff-hanger with the launch of the world’s first anti-dengue vaccine in Mexico giving hope to the South Asian country.
New Delhi: The newly-developed female viagra “Addyi” will take at least three to four years to be introduced in the Indian market as trials are still on to ascertain its long-term effects, doctors said on Thursday.
Mumbai (IANS): The Maharashtra Food and Drugs Administration (FDA) has ordered the filing of a first information report (FIR) against e-commerce major Snapdeal.com’s CEO, directors and distributors on charges of selling prescription drugs online, a top official said here on Friday.
Bengaluru (IANS): Cord blood banking (CBB) with dubious benefits has become a money-making scam in India and needs tighter control to protect gullible parents from being exploited, top medical researchers say.
New Delhi (IANS): Haemophilia care providers on Friday urged India’s drug regulator to be more sensitive to their needs and quickly clear the import of medicines donated from abroad.
New Delhi: A study conducted by researchers from the department of gastroenterology, Sir Ganga Ram Hospital on 777 patients of Hepatitis C from 2008 to 2014 reveals that the currently available treatment regimen in India for Hepatitis C could cure only 14 per cent of the patients.